Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches
2009 ◽
Vol 144
(1)
◽
pp. 107-115
◽
2017 ◽
Vol 178
(2)
◽
pp. 257-266
◽
2006 ◽
Vol 133
(4)
◽
pp. 382-388
◽
2001 ◽
Vol 15
(2)
◽
pp. 99-103
◽
2015 ◽
Vol 16
(4)
◽
pp. 465-474
◽
2001 ◽
Vol 114
(2)
◽
pp. 281-289
◽
The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia
1989 ◽
Vol 73
(2)
◽
pp. 173-180
◽